A new frontier for R-CHOP: is two better than one?
- PMID: 37856095
- DOI: 10.1182/blood.2023021521
A new frontier for R-CHOP: is two better than one?
Comment on
-
Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study.Blood. 2023 Oct 19;142(16):1348-1358. doi: 10.1182/blood.2023020637. Blood. 2023. PMID: 37369099 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials

